User menu

Diabetic macro- and microvascular disease in type 2 diabetes

Bibliographic reference Hermans, Michel. Diabetic macro- and microvascular disease in type 2 diabetes. In: Diabetes and Vascular Disease Research, Vol. 4, no. SUPPL. 2 (2007)
Permanent URL
  1. Turner Robert C., Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49), 10.1001/jama.281.21.2005
  2. Levy J., Atkinson A.B., Bell P.M., McCance D.R., Hadden D.R., Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in Type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study, 10.1002/(sici)1096-9136(199804)15:4<290::aid-dia570>;2-m
  3. Diabetes, 42, 17663 (1993)
  4. Diabet Med, 13, S67 (1996)
  5. Mt Sinai J Med, 69, 280 (2002)
  6. Louvain Med, 125, S82 (2006)
  7. Kaiser N., Sasson S., Feener E. P., Boukobza-Vardi N., Higashi S., Moller D. E., Davidheiser S., Przybylski R. J., King G. L., Differential Regulation of Glucose Transport and Transporters by Glucose in Vascular Endothelial and Smooth Muscle Cells, 10.2337/diab.42.1.80
  8. Brownlee M., The Pathobiology of Diabetic Complications: A Unifying Mechanism, 10.2337/diabetes.54.6.1615
  9. Park C. W., Kim H. W., Ko S. H., Chung H. W., Lim S. W., Yang C. W., Chang Y. S., Sugawara A., Guan Y., Breyer M. D., Accelerated Diabetic Nephropathy in Mice Lacking the Peroxisome Proliferator-Activated Receptor  , 10.2337/diabetes.55.04.06.db05-1329
  10. Pille J.-V., Varet J., Vincent L., Mirshahi P., Legrand E., Opolon P., Mishal Z., Soria J., Li H., Soria C., Fenofibrate inhibits angiogenesis in vitro and in vivo, 10.1007/s00018-003-2322-6